Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Lowered to $375 at Cowen

October 20, 2021 5:59 PM
Cowen analyst Phil Nadeau lowered the price target on Biogen (NASDAQ: BIIB) to $375.00 (from $450.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles